Logo

Combimatrix Slated to Receive $2.3M in Defense Dept. Funding

Jul 23, 2004

NEW YORK, July 23 (GenomeWeb News) - Combimatrix will receive $2.3 million from a US Defense Department spending bill that was slated to be passed by Congress this week, the company said yesterday.

 

The funding is for the company's development of a microarray-based biosensor system to monitor biological and chemical agents that could pose threats. The system is being developed both for testing in the field of combat as well as within the US.

 

Combimatrix was originally awarded a $5.9 million contract in March by the Defense Department to develop this system. This new, additin funding is for continued development of the system.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.